Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2014 1
2018 1
2020 5
2021 3
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: CCR5: A receptor at the center stage in infection.
Ellwanger JH, Secchi M, Aliberti J, Vangelista L. Ellwanger JH, et al. Among authors: secchi m. Front Immunol. 2022 Oct 18;13:1054430. doi: 10.3389/fimmu.2022.1054430. eCollection 2022. Front Immunol. 2022. PMID: 36330512 Free PMC article. No abstract available.
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.
Halliday A, Long AE, Baum HE, Thomas AC, Shelley KL, Oliver E, Gupta K, Francis O, Williamson MK, Di Bartolo N, Randell MJ, Ben-Khoud Y, Kelland I, Mortimer G, Ball O, Plumptre C, Chandler K, Obst U, Secchi M, Piemonti L, Lampasona V, Smith J, Gregorova M, Knezevic L, Metz J, Barr R, Morales-Aza B, Oliver J, Collingwood L, Hitchings B, Ring S, Wooldridge L, Rivino L, Timpson N, McKernon J, Muir P, Hamilton F, Arnold D, Woolfson DN, Goenka A, Davidson AD, Toye AM, Berger I, Bailey M, Gillespie KM, Williams AJK, Finn A. Halliday A, et al. Among authors: secchi m. Front Immunol. 2022 Nov 9;13:968317. doi: 10.3389/fimmu.2022.968317. eCollection 2022. Front Immunol. 2022. PMID: 36439154 Free PMC article.
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, De Angelis ML, Baratella M, Bazzigaluppi E, Venturi G, Sironi F, Canitano A, Marzinotto I, Tresoldi C, Ciceri F, Piemonti L, Negri D, Cara A, Lampasona V, Scarlatti G. Dispinseri S, et al. Among authors: secchi m. Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8. Nat Commun. 2021. PMID: 33976165 Free PMC article.
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.
Dispinseri S, Lampasona V, Secchi M, Cara A, Bazzigaluppi E, Negri D, Brigatti C, Pirillo MF, Marzinotto I, Borghi M, Rovere-Querini P, Tresoldi C, Ciceri F, Scavini M, Scarlatti G, Piemonti L. Dispinseri S, et al. Among authors: secchi m. J Clin Endocrinol Metab. 2021 Apr 23;106(5):1472-1481. doi: 10.1210/clinem/dgab055. J Clin Endocrinol Metab. 2021. PMID: 33513242 Free PMC article.
23 results